Tokyo Tape
Sign in
← Techmatrix

Quarterly report · Q3

3762.TEDINET S100SW6N
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥38.0bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥13.4bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥46.0bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥32.3bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥11.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income¥3.8bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥1.5bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥2.8bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥913m2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥1.5bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥5.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥2.8bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥893m2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥2.3bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥933m2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥514m2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥2.7bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥1.1bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥3.6bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥1.9bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥614m2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥73.4bnat 2023-12-31Cons.Assets IFRS
Total assets¥65.7bnat 2023-03-31Cons.Assets IFRS
Total assets¥62.2bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥47.7bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥41.8bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥25.7bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥23.9bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥22.1bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥20.2bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥20.6bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥19.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥17.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥16.7bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥20.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥16.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥18.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥2.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥6.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥781m2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥3.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥393m2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥58.542023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥23.252023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥73.912022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥39.522022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥12.872022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥58.332023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.172023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥73.672022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥39.412022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥12.832022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio28.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.9%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥330m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥330m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue2023-04-01 → 2023-12-31¥6.1bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue external2023-04-01 → 2023-12-31¥5.9bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥185m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentsegment profit2023-04-01 → 2023-12-31¥148m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue2023-04-01 → 2023-12-31¥25.5bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue external2023-04-01 → 2023-12-31¥25.3bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥146m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentsegment profit2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥895m
—segment totalrevenue2023-04-01 → 2023-12-31¥38.3bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥38.0bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥330m
—segment totalsegment profit2023-04-01 → 2023-12-31¥3.8bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥349m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥349m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue2022-04-01 → 2022-12-31¥5.3bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue external2022-04-01 → 2022-12-31¥5.2bn
jpcrp040300-q3r_E05463-000Application Servicereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥116m
jpcrp040300-q3r_E05463-000Application Servicereportable segmentsegment profit2022-04-01 → 2022-12-31−¥138m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue2022-04-01 → 2022-12-31¥21.2bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue external2022-04-01 → 2022-12-31¥21.0bn
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥230m
jpcrp040300-q3r_E05463-000Information Infrastructurereportable segmentsegment profit2022-04-01 → 2022-12-31¥1.9bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.1bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.1bn
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05463-000Medical System Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.0bn
—segment totalrevenue2022-04-01 → 2022-12-31¥32.6bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥32.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥349m
—segment totalsegment profit2022-04-01 → 2022-12-31¥2.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 874
ItemContextValueUnit
Net increase decrease in short term borrowings fin cf IFRSPrior1YTDDuration-25000000JPY
Net increase decrease in short term borrowings fin cf IFRSCurrentYTDDuration－JPY
Repayments of long term borrowings fin cf IFRSPrior1YTDDuration-150000000JPY
Repayments of long term borrowings fin cf IFRSCurrentYTDDuration-150000000JPY
Proceeds from other financial liabilities fin cf IFRSPrior1YTDDuration－JPY
Proceeds from other financial liabilities fin cf IFRSCurrentYTDDuration2451000000JPY
Payments of other financial liabilities fin cf IFRSPrior1YTDDuration－JPY
Payments of other financial liabilities fin cf IFRSCurrentYTDDuration-313898000JPY
Dividends paid fin cf IFRSPrior1YTDDuration-795180000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-998125000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-1018153000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-592436000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration-248475000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration－JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSPrior1YTDDuration1200577000JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSCurrentYTDDuration－JPY
Other fin cf IFRSPrior1YTDDuration-7960000JPY
Other fin cf IFRSCurrentYTDDuration-3213000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-1044191000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration393326000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration-1654000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-2670000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-1821318000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-3328956000JPY
Cash and cash equivalents IFRSPrior2YearInstant18155903000JPY
Cash and cash equivalents IFRSPrior1YearInstant20071540000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant16334584000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant16742583000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember21017450000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember5151830000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember6116175000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember32285456000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration32285456000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember230043000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember116284000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember2336000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember348664000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-348664000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember21247494000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember5268115000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember6118511000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember32634121000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-348664000JPY
Revenue IFRSPrior1YTDDuration32285456000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000InformationInfrastructureReportableSegmentMember1928296000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000ApplicationServiceReportableSegmentMember-138492000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q3r_E05463-000MedicalSystemBusinessReportableSegmentMember1038582000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember2828386000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass